title: Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.
abstract: BACKGROUND
  The objective of this study was to investigate the stability of ceftazidime and cephazolin in a 7.5% icodextrin or pH neutral peritoneal dialysis (PD) solution.
  
  
  METHODS
  Ceftazidime and cephazolin were injected into either a 7.5% icodextrin or pH neutral PD bag to obtain the concentration of 125 mg/L of each antibiotic. A total of nine 7.5% icodextrin or pH neutral PD bags containing ceftazidime and cephazolin were prepared and stored at 1 of 3 different temperatures: 4°C in a domestic refrigerator; 25°C at room temperature; or 37°C (body temperature) in an incubator. An aliquot was withdrawn immediately before (0 hour) or after 12, 24, 48, 96, 120, 144, 168 and 336 hours of storage. Each sample was analyzed in duplicate for the concentration of ceftazidime and cephazolin using a stability-indicating high-performance liquid chromatography technique. Ceftazidime and cephazolin were considered stable if they retained more than 90% of their initial concentration. Samples were also assessed for pH, colour changes and evidence of precipitation immediately after preparation and on each day of analysis.
  
  
  RESULTS
  Ceftazidime and cephazolin in both types of PD solution retained more than 90% of their initial concentration for 168 and 336 hours respectively when stored at 4°C. Both of the antibiotics lost more than 10% of the initial concentration after 24 hours of storage at 25 or 37°C. There was no evidence of precipitation at any time under the tested storage conditions. Change in the pH and color was observed at 25 and 37°C, but not at 4°C.
  
  
  CONCLUSIONS
  Premixed ceftazidime and cephazolin in a 7.5% icodextrin or pH neutral PD solution is stable for at least 168 hours when refrigerated. This allows the preparation of PD bags in advance, avoiding the necessity for daily preparation. Both the antibiotics are stable for at least 24 hours at 25 and 37°C, permitting storage at room temperature and pre-warming of PD bags to body temperature prior to its administration.
authors.affiliation: School of Pharmacy,1 University of Tasmania, Hobart, Tasmania, Australia;
authors.forename: Rahul P
authors.initials: RP
authors.lastname: Patel
authors.forename: Madhur D
authors.initials: MD
authors.lastname: Shastri
authors.forename: Mohammad
authors.initials: M
authors.lastname: Bakkari
authors.forename: Troy
authors.initials: T
authors.lastname: Wanandy
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Jose
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry*; D002437:Cefazolin / Q000737:chemistry*; D002442:Ceftazidime / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D005936:Glucans / Q000737:chemistry*; D005947:Glucose / Q000737:chemistry*; D015312:Hemodialysis Solutions / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D000077607:Icodextrin; D010530:Peritoneal Dialysis
chemical_list: D000900:Anti-Bacterial Agents; D005936:Glucans; D015312:Hemodialysis Solutions; D000077607:Icodextrin; D002442:Ceftazidime; D002437:Cefazolin; D005947:Glucose
keywords: Ceftazidime; cephazolin; high-performance liquid chromatography; icodextrin; pH neutral; peritoneal dialysis; stability